These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 27560688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
    Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C, Avril A, Pelat T, Urbain R, Fontayne A, Thullier P, Sesardic D, Lindström M, Hust M, Korkeala H.
    Toxins (Basel); 2016 Sep 12; 8(9):. PubMed ID: 27626446
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T, Kitamura M, Amatsu S, Yamaguchi A, Kobayashi N, Yutani M, Fujinaga Y.
    Microbiol Immunol; 2024 Oct 12; 68(10):348-358. PubMed ID: 39239735
    [Abstract] [Full Text] [Related]

  • 12. [Monoclonal antibodies to type A, B, E and F botulinum neurotoxins].
    Abbasova SG, Ruddenko NV, Gorokhovatskiĭ AIu, Kapralova MV, Vinogradova ID, Vertiev IuV, Nesmeianov VA, Grishin EV.
    Bioorg Khim; 2011 Oct 12; 37(3):344-53. PubMed ID: 21899049
    [Abstract] [Full Text] [Related]

  • 13. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B, Colliou N, Zadeh M, Ge Y, Gong M, Owen JL, Valletti M, Jobin C, Mohamadzadeh M.
    Vaccine; 2018 Jan 02; 36(1):155-164. PubMed ID: 29180028
    [Abstract] [Full Text] [Related]

  • 14. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S, Tepp WH, Bradshaw M, Kalb SR, Dykes JK, Lin G, Nawrocki EM, Pier CL, Barr JR, Maslanka SE, Johnson EA.
    mSphere; 2016 Jan 02; 1(1):. PubMed ID: 27303710
    [Abstract] [Full Text] [Related]

  • 15. Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype B.
    Zhou H, Zhou B, Pellett S, Johnson EA, Janda KD.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):662-4. PubMed ID: 19112017
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
    Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX.
    Appl Microbiol Biotechnol; 2023 May 01; 107(10):3205-3216. PubMed ID: 37058230
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
    Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD.
    Protein Eng Des Sel; 2011 Mar 01; 24(3):321-31. PubMed ID: 21149386
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M, Maeda H, Kohda T, Nozaki C, Takahashi M, Kozaki S.
    Jpn J Infect Dis; 2013 Mar 01; 66(1):46-50. PubMed ID: 23429085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.